|
|
English
version
For å registrere i Cristin må du være vitenskapelig eller administrativt ansatt.
|
|
|
|
|
|
|
|
|
2019
|
1. |
Flem-Karlsen, Karine; Tekle, Christina; Øyjord, Tove Ragnhild; Flørenes, Vivi Ann; Mælandsmo, Gunhild Mari; Fodstad, Øystein; Nunes-Xavier, Caroline Elisabeth. p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance. Scientific Reports 2019 ;Volum 9.(1) UiT UiO OUS
Untitled
|
|
2. |
Flørenes, Vivi Ann; Flem-Karlsen, Karine; McFadden, Erin; Bergheim, Inger Riise; Nygaard, Vigdis; Nygård, Vegard Mokleiv; Farstad, Inger Nina; Øy, Geir Frode; Emilsen, Elisabeth; Fleten, Karianne Giller; Ree, Anne Hansen; Flatmark, Kjersti; Gullestad, Hans Petter; Hermann, Robert; Ryder, Truls; Wernhoff, Patrik; Mælandsmo, Gunhild Mari. A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases. Translational Oncology 2019 ;Volum 12.(7) s. 951-958 UiO OUS AHUS UiT
Untitled
|
|
3. |
Juraleviciute, Marina; Pozniak, Joanna; Nsengimana, Jérémie; Harland, Mark; Randerson-Moor, Juliette; Vernhoff, Patrik; Bassarova, Assia Vassileva; Øy, Geir Frode; Trøen, Gunhild; Flørenes, Vivi Ann; Bishop, David Timothy; Herlyn, Meenhard; Newton-Bishop, Julia; Slipicevic, Ana. MX 2 is a novel regulator of cell cycle in melanoma cells. Pigment Cell & Melanoma Research 2019 OUS
Untitled
|
|
4. |
Karlsen, Karine Flem; McFadden, Erin; Omar, Nasrin; Haugen, Mads Haugland; Øy, Geir Frode; Ryder, Truls; Gullestad, Hans Petter; Hermann, Robert; Mælandsmo, Gunhild Mari; Flørenes, Vivi Ann. Targeting AXL and the DNA damage response pathway as a novel therapeutic strategy in melanoma. Molecular Cancer Therapeutics 2019 ;Volum 19.(3) s. 895-905 OUS UiO
Untitled
|
|